We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Antioxidants Cause Melanoma to Metastasize Faster

By HospiMedica International staff writers
Posted on 19 Oct 2015
Print article
A new study suggests that antioxidant use can double the rate of melanoma metastasis in mice, reinforcing findings that indicate they can hasten the progression of lung cancer.

Researchers at Sahlgrenska Academy (Göteborg, Sweden) and the University of Gothenburg (Sweden) conducted a study in a murine model to examine the impact of using N-acetylcysteine (NAC, an antioxidant that is a specially modified form of the dietary amino acid cysteine), and the soluble vitamin E analog Trolox on progression of malignant melanoma. The study was launched following previous trials that showed that antioxidants actually increase cancer risk, and could even accelerate the progression of primary lung tumors.

The results showed that NAC increases lymph node metastases, but has no impact on number and size of primary tumors. Similarly, NAC and Trolox increase the migration and invasive properties of human malignant melanoma cells, but do not affect proliferation. Both increased the ratio between reduced and oxidized glutathione in melanoma cells and in lymph node metastases, with increased migration dependent on new glutathione synthesis. NAC and Trolox also increase activation of the small guanosine triphosphatase RHOA; blocking downstream RHOA signaling abolished antioxidant-induced migration. The study was published on October 7, 2015, in Science Translational Medicine.

“Taking nutritional supplements containing antioxidants may unintentionally hasten the progression of a small tumor or premalignant lesion, neither of which is possible to detect,” said senior author Prof. Martin Bergö, PhD, of the Sahlgrenska Academy. “Our current research combined with information from large clinical trials with antioxidants suggests that people who have been recently diagnosed with cancer should avoid such supplements."

Oxidation is a chemical reaction involving the loss of electrons or an increase in oxidation state, a process that can produce free radicals. As well-established, long term evidence shows that free radicals can cause cancer, many researchers thought that antioxidants, which destroy free radicals, could provide protection against the disease. Accordingly, antioxidants are found in many nutritional supplements, touted as a means of preventing cancer. Antioxidant use is particularly relevant in melanoma, not only because melanoma cells are known to be sensitive to free radicals, but because the cells can be exposed to antioxidants by non-dietary means as well.

Related Links:

Sahlgrenska Academy
University of Gothenburg


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Bronchoscope
EB-500

Print article

Channels

Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.